Epigenetic Alterations from Barrett's Esophagus to Esophageal Adenocarcinoma

被引:7
作者
Ergun, Pelin [1 ,2 ]
Kipcak, Sezgi [1 ,3 ]
Bor, Serhat [1 ]
机构
[1] Ege Univ, Fac Med, Div Gastroenterol, Ege Reflux Study Grp, TR-35040 Izmir, Turkiye
[2] Ege Univ, Fac Med, Dept Med Biochem, TR-35040 Izmir, Turkiye
[3] Ege Univ, Fac Med, Dept Med Biol, TR-35040 Izmir, Turkiye
关键词
Barrett's esophagus; adenocarcinoma; epigenetics; methylations; miRNA; PROMOTER HYPERMETHYLATION; E-CADHERIN; NEOPLASTIC PROGRESSION; MICRORNA EXPRESSION; TUMOR-SUPPRESSOR; MALIGNANT PROGRESSION; MOLECULAR ALTERATIONS; HISTONE DEACETYLASES; GASTRIC-CANCER; EARLY EVENT;
D O I
10.3390/ijms24097817
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Barrett's esophagus (BE) is a disease entity that is a sequela of chronic gastroesophageal reflux disease that may result in esophageal adenocarcinoma (EAC) due to columnar epithelial dysplasia. The histological degree of dysplasia is the sole biomarker frequently utilized by clinicians. However, the cost of endoscopy and the fact that the degree of dysplasia does not progress in many patients with BE diminish the effectiveness of histological grading as a perfect biomarker. Multiple or more quantitative biomarkers are required by clinicians since early diagnosis is crucial in esophageal adenocancers, which have a high mortality rate. The presence of epigenetic factors in the early stages of this neoplastic transformation holds promise as a predictive biomarker. In this review, current studies on DNA methylations, histone modifications, and noncoding RNAs (miRNAs) that have been discovered during the progression from BE dysplasia to EAC were collated.
引用
收藏
页数:18
相关论文
共 120 条
[1]   Widespread Hypomethylation Occurs Early and Synergizes with Gene Amplification during Esophageal Carcinogenesis [J].
Alvarez, Hector ;
Opalinska, Joanna ;
Zhou, Li ;
Sohal, Davendra ;
Fazzari, Melissa J. ;
Yu, Yiting ;
Montagna, Christina ;
Montgomery, Elizabeth A. ;
Canto, Marcia ;
Dunbar, Kerry B. ;
Wang, Jean ;
Carlos Roa, Juan ;
Mo, Yongkai ;
Bhagat, Tushar ;
Ramesh, K. H. ;
Cannizzaro, Linda ;
Mollenhauer, J. ;
Thompson, Reid F. ;
Suzuki, Masako ;
Meltzer, Stephen J. ;
Melnick, Ari ;
Greally, John M. ;
Maitra, Anirban ;
Verma, Amit .
PLOS GENETICS, 2011, 7 (03)
[2]   NADPH oxidase 5 (NOX5)induced reactive oxygen signaling modulates normoxic HIF-1 and p27Kip1 expression in malignant melanoma and other human tumors [J].
Antony, Smitha ;
Jiang, Guojian ;
Wu, Yongzhong ;
Meitzler, Jennifer L. ;
Makhlouf, Hala R. ;
Haines, Diana C. ;
Butcher, Donna ;
Hoon, Dave S. ;
Ji, Jiuping ;
Zhang, Yiping ;
Juhasz, Agnes ;
Lu, Jiamo ;
Liu, Han ;
Dahan, Iris ;
Konate, Mariam ;
Roy, Krishnendu K. ;
Doroshow, James H. .
MOLECULAR CARCINOGENESIS, 2017, 56 (12) :2643-2662
[3]   Discovery and Validation of Barrett's Esophagus MicroRNA Transcriptome by Next Generation Sequencing [J].
Bansal, Ajay ;
Lee, In-Hee ;
Hong, Xiaoman ;
Mathur, Sharad C. ;
Tawfik, Ossama ;
Rastogi, Amit ;
Buttar, Navtej ;
Visvanathan, Mahesh ;
Sharma, Prateek ;
Christenson, Lane K. .
PLOS ONE, 2013, 8 (01)
[4]   Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS [J].
Barradas, Marta ;
Anderton, Emma ;
Acosta, Juan Carlos ;
Li, SiDe ;
Banito, Ana ;
Rodriguez-Niedenfuehr, Marc ;
Maertens, Goedele ;
Banck, Michaela ;
Zhou, Ming-Ming ;
Walsh, Martin J. ;
Peters, Gordon ;
Gil, Jesus .
GENES & DEVELOPMENT, 2009, 23 (10) :1177-1182
[5]   CHRONIC PEPTIC ULCER OF THE OESOPHAGUS AND OESOPHAGITIS [J].
BARRETT, NR .
BRITISH JOURNAL OF SURGERY, 1950, 38 (150) :175-182
[6]   The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma [J].
Baumann, S. ;
Keller, G. ;
Puehringer, F. ;
Napieralski, R. ;
Feith, M. ;
Langer, R. ;
Hoefler, H. ;
Stein, H. J. ;
Sarbia, M. .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (02) :264-268
[7]   p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus [J].
Bian, YS ;
Osterheld, MC ;
Fontolliet, C ;
Bosman, FT ;
Benhattar, J .
GASTROENTEROLOGY, 2002, 122 (04) :1113-1121
[8]   Detection of LINE-1 hypomethylation in cfDNA of Esophageal Adenocarcinoma Patients [J].
Boldrin, Elisa ;
Curtarello, Matteo ;
Dallan, Marco ;
Alfieri, Rita ;
Realdon, Stefano ;
Fassan, Matteo ;
Saggioro, Daniela .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
[9]   How is the gastroesophageal reflux disease prevalence, incidence, and frequency of complications (stricture/esophagitis/Barrett's esophagus/carcinoma) in Turkey compared to other geographical regions globally? [J].
Bor, Serhat ;
Yuksel, Elif Saritas .
TURKISH JOURNAL OF GASTROENTEROLOGY, 2017, 28 :S4-S9
[10]  
Brock MV, 2003, CLIN CANCER RES, V9, P2912